Skip to content

Clinical trials

Completed Phase 2 Migraine Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Migraine Disorders Phase: Phase 2 Status: Completed Clear all

91 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20034
20041
20056
20066
20077
20086
20099
20102
20111
20125
20131
20146
20151
20163
20178
20184
20193
20203
20216
20222
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed91

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company7
Alexza Pharmaceuticals, Inc.5
Merck Sharp & Dohme LLC4
Allodynic Therapeutics, Inc3
Amgen3
GlaxoSmithKline3
Allergan2
Boehringer Ingelheim2
Children's Hospital Medical Center, Cincinnati2
H. Lundbeck A/S2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Migraine Disorders91
Headache21
Epilepsy4
Migraine with Aura4
Migraine without Aura3
Fibromyalgia2
Irritable Bowel Syndrome2
Nausea2
Pain2
Vomiting2

Trials

Showing 1 to 25 of 91. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.